Newly-Formed Ancora Biotech Will Continue Operations of Teneobio Spin-offs After Successful Acquisit…

NEWARK, Calif.–(BUSINESS WIRE)–Ancora Biotech announced, in connection with the closing of the acquisition of Teneobio, Inc., by Amgen Inc., that Teneobio’s former shareholders and their representatives will provide oversight of three previous affiliates of Teneobio, including…